Pharma OHD ApS: Financial statements 2024
CVR: 43088939
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma OHD ApS (CVR 43088939) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -4,991 and a net result of DKK 2,066,741 compared with DKK 2,908,481 the year before. Equity in the 2024 report amounted to DKK 8,299,124. The solvency ratio was 53.5%.
- Gross Profit
- DKK -4,991
- Profit/Loss
- DKK 2,066,741
- Equity
- DKK 8,299,124
- Total Assets
- DKK 15,516,378
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma OHD ApS has published its annual report for 2023. Gross profit came to DKK -22,810, and the net result was DKK 2,908,481.
About Pharma OHD ApS
Pharma OHD ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Gustav Muus Ølgaard and Johan Lønsmann Poulsen. The company is owned by LP Family Holding ApS and House of Muus Ølgaard ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -25,766 and a net result of DKK 3,988,020 compared with DKK 2,066,741 the year before. Equity in the 2025 report amounted to DKK 12,287,144.
